MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Analyst Earnings Estimates
NASDAQ:MDGL - Nasdaq - US5588681057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 193.53% | N/A 102.98% | N/A 67.93% | N/A 50.37% | N/A 36.38% | N/A 15.19% | N/A 38.11% | N/A -16.35% | |||||||||||
| EBITDA YoY % growth | -83.33M | -3.2M 96.16% | -25.2M -687.50% | -32.02M -27.06% | -40.6M -26.80% | -94.89M -133.72% | -206.23M -117.34% | -242.09M -17.39% | -293.13M -21.08% | -379.969M -29.62% | N/A -44.39% | N/A 14.54% | N/A 87.10% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -84M | -3.2M 96.19% | -25.2M -687.50% | -32.1M -27.38% | -40.7M -26.79% | -95M -133.42% | -206.7M -117.58% | -242.5M -17.32% | -293.6M -21.07% | -380.496M -29.60% | N/A -43.88% | N/A 34.96% | N/A 108.30% | N/A 2,519.55% | N/A 101.67% | N/A 61.20% | N/A 15.81% | N/A 29.05% | N/A -15.49% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -31.50 | -19.25 38.89% | -4.71 75.53% | -2.54 46.07% | -2.21 12.99% | -5.45 -146.61% | -13.09 -140.18% | -14.61 -11.61% | -17.23 -17.93% | -19.94 -15.73% | N/A -20.07% | N/A 42.34% | N/A 123.44% | N/A 864.99% | N/A 85.17% | N/A 63.79% | N/A 17.31% | N/A 21.73% | N/A -40.75% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -4.39 22.66% | -3.86 47.70% | -3.49 50.90% | -3.08 37.33% | -2.37 46.01% | -2.34 39.27% | -0.38 89.04% | 1.58 151.35% | 6.69 381.90% |
| Revenue Q2Q % growth | 99.069M | 105.35M | 126.15M 761.80% | 143.17M 130.27% | 166.42M 67.98% | 135.61M 28.72% | 169.51M 34.37% | 220.37M 53.92% | 439.83M 164.29% |
| EBITDA Q2Q % growth | -109.344M 6.26% | -108.028M 28.87% | -97.267M 40.00% | -81.6M 29.39% | -61.761M 43.52% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -101.529M 13.35% | -94.466M 37.87% | -88.705M 45.42% | -81.551M 29.88% | -65.793M 35.20% | -70.67M 25.19% | -48.437M 45.40% | -14.805M 81.85% | 174.9M 365.83% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -4.92 7.87% | -7.05 | 2.13 | 30.22% |
| Q2 2024 Q2Q % growth | -7.10 -51.39% | -7.68 | 0.58 | 7.50% |
| Q1 2024 Q2Q % growth | -7.38 -74.47% | -6.41 | -0.97 | -15.12% |
| Q4 2023 Q2Q % growth | -5.68 -14.06% | -5.39 | -0.29 | -5.38% |
| Q3 2023 Q2Q % growth | -5.34 -12.42% | -5.02 | -0.32 | -6.30% |
| Q2 2023 Q2Q % growth | -4.69 -13.29% | -4.67 | -0.02 | -0.37% |
| Q1 2023 Q2Q % growth | -4.23 -25.89% | -5.04 | 0.81 | 16.00% |
| Q4 2022 Q2Q % growth | -4.98 -31.75% | -4.65 | -0.33 | -7.16% |
| Q3 2022 Q2Q % growth | -4.75 -25.33% | -4.24 | -0.51 | -12.11% |
| Q2 2022 Q2Q % growth | -4.14 -11.29% | -3.77 | -0.37 | -9.78% |
| Q1 2022 Q2Q % growth | -3.36 -1.20% | -3.69 | 0.33 | 9.02% |
| Q4 2021 Q2Q % growth | -3.78 1.05% | -3.95 | 0.17 | 4.41% |
| Q3 2021 Q2Q % growth | -3.79 -1.07% | -3.98 | 0.19 | 4.67% |
| Q2 2021 Q2Q % growth | -3.72 -16.98% | -3.66 | -0.06 | -1.75% |
| Q1 2021 Q2Q % growth | -3.32 -41.88% | -3.92 | 0.60 | 15.32% |
| Q4 2020 Q2Q % growth | -3.82 -112.22% | -3.93 | 0.11 | 2.85% |
| Q3 2020 Q2Q % growth | -3.75 -169.78% | -3.36 | -0.39 | -11.47% |
| Q2 2020 Q2Q % growth | -3.18 -148.44% | -2.50 | -0.68 | -27.07% |
| Q1 2020 Q2Q % growth | -2.34 -138.78% | -1.98 | -0.36 | -18.07% |
| Q4 2019 Q2Q % growth | -1.80 | -1.68 | -0.12 | -6.99% |
| Q3 2019 Q2Q % growth | -1.39 | -1.57 | 0.18 | 11.19% |
| Q2 2019 Q2Q % growth | -1.28 | -1.22 | -0.06 | -4.64% |
| Q1 2019 Q2Q % growth | -0.98 | -0.99 | 0.01 | 0.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 62.175M | 34.873M | 27.302M | 78.29% |
| Q2 2024 Q2Q % growth | 14.638M | 3.981M | 10.657M | 267.70% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.74% | 0.32% | 0.75% | 0.69% |
| Revenue | 6.79% | 4.93% | 1.44% | 2.7% |